Humana (HUM) and Cohere Health Expand Prior Authorization Partnership
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Humana (HUM) PT Lowered to $353 at RBC Capital
April 25, 2024 6:44 AM EDTRBC Capital analyst Frank Morgan lowered the price target on Humana (NYSE: HUM) to $353.00 (from $415.00) while maintaining a Outperform rating.
The analyst comments "Despite taking 2025 adjusted EPS growth targets off the table for now, management stressed its continued commitment to margin... More
Humana (HUM) PT Lowered to $360 at Cantor Fitzgerald
April 25, 2024 6:32 AM EDTCantor Fitzgerald analyst Sarah James lowered the price target on Humana (NYSE: HUM) to $360.00 (from $391.00) while maintaining a Neutral rating.
The analyst comments "On the positive side, HUM beat the quarter (expected by investors) and held 2024 guide (also expected by... More
